In less than nine months, the UK must have new rules in place to regulate the approval of medical equipment, but so far, the British successor to the CE mark remains to be seen.
Medtronic’s insulin pump pairs wirelessly with its components – which constitutes a potential cybersecurity risk, the US health authority says. The company has had this problem before.
A 45-year-old man accused of having abused confidential knowledge while employed at Ambu has been fined DKK 100,000 (USD 13,500).
The Danish medtech firm has production facilities in China, meaning it will avoid a potential ban on medical equipment not made in the country, which is being put in place by some hospitals on governmental request.
Ranking 300 Nordic companies, ESG consulting firm Position Green has placed Coloplast at the top of life science firms based in Denmark when it comes to ESG reporting.
A 45-year-old man is accused of having abused confidential knowledge while employed at Ambu, selling shares at profit of DKK 500,000 shortly after learning that a product was to be discontinued.
The EU will soon make a decision on reference labs required by its new regulation, IVDR. Denmark should be a contender, says the Danish Chamber of Commerce, highlighting benefits.
Workers’ wages have gone up in Hungary, where the Danish medtech firm makes most of its products. Now, part of the production is moving to where the grass is greener – across the Atlantic in Costa Rica.
New Nordic sustainable packaging criteria will be included in a Danish procurement tender for public hospitals, although the ”economy” and ”’user-friendliness” criteria are both weighted as twice as important.
The US-based medtech company has found its new chief executive in Steffen Hovard, who spent more than a decade at Danish medtech company Coloplast.
Increasing energy prices, wage inflation in Hungary, sky-high freight rates, and unchecked raw material expenses are costing Coloplast dearly. Now, the company’s head of global operations acknowledges he should have laid better plans.
Though she was previously against gender quotas, Ambu’s new chief executive has had a change of heart.
Kristian Villumsen, CEO of Coloplast, has learned lessons about how to speed up the medtech company’s future innovation, after some challenging development years that are finally culminating in the launch of completely new product types.
The hard-line Covid-19 policy in China means lower activity and growth levels, and that is a problem for the medtech firm, which has a large market share in the country.
A number of initiatives will help the Danish medtech firm weather the storm of increasing energy costs and supply chain bottlenecks.
Atos Medical, the Danish medtech firm’s latest acquisition, will be fully integrated within a couple of years, says Coloplast CEO Kristian Villumsen, noting that the next acquisition will probably be smaller in scale.
The pandemic in China, inflation, bottlenecking, and more: Coloplast’s problems are many, but work to meet goals set in Strive25, the medtech firm’s long-term plan, is still ongoing.
Britt Meelby Jensen has spent over DKK 3m (USD 406,000) on Ambu shares.
According to CEO Britt Meelby Jensen, Ambu has the biggest market share when it comes to single-use scopes, though she highlights the competition is heating up fast.
The Danish medtech company will dismiss 200 employees globally before the end of September, and has now concluded the process at its headquarters in Denmark.
Like many other exporting companies, the Danish medtech company has been enjoying a currency tailwind in the US – and the forecast says the effect will continue, according to CEO Britt Meelby Jensen.
The Danish medtech firm has sold 400,000 endoscopes in the third quarter of financial 2021/2022.
The medtech company had already downgraded its expectations for the full year earlier, publicizing some figures for the financial performance then, which have now been confirmed in the Q3 report.
The Danish state’s spinout company has bought two US-based diagnostics firms in the past two years, and majority owner Adelis Equity Partners predicts a future with more acquisitions.
Increasing energy uncertainty and prices are affecting the Danish medtech company, which is mitigating the consequences by raising its product prices, among other things.
Ambitious Business Relationship Manager for the Danish Medicines Agency 
Nordic Key Account Manager, Hollister & Dansac 
Senior CMC & Device Project Manager 
Senior Clinical Research Scientist 
Manager for Process Support - 1st line support 
Clinical Project Lead LIMS Super User for Operations at ALK 
Chief Business Officer 
Product specialist CMC Writer 
Pharmacovigilance & Regulatory Assistant with an interest in non-fiction Sales Manager Denmark Drug Safety Associate Regulatory Affairs CMC Specialist 
Senior/lead consultant at Emendo Engineering 
Product specialist in Cardio Rhythm Management, Zealand Head of Commercial / Sales Manager, Denmark 
Senior CMC Regulatory Manager 
Scientist Radiochemistry Pharmacovigilance & Regulatory Officer Senior Manager, System Change & Release Management Senior Manager, QA GMP Regulatory Project Manager 
Vice President, Medical Affairs Pharmacovigliance (Associate) Director or Senior Specialist 
